SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec Lifesciences appoints audit committee member

29 May 2012 Evaluate

Astec Lifesciences has informed that the board of directors of the company at its meeting held on May 28, 2012, has recommended the appointment of Mandar K Patil as a member of audit committee for the approval of board of directors with effect from May 27, 2012 and a dividend of fifty paise per share (i.e. 5% on the face value of Rs 10 each) for the approval of the shareholders at the ensuing annual general meeting.

Further the board appointed Mandar K Patil as Non-Executive & Independent Director on the board of the company and member of audit committee with effect from May 27, 2012.

The above information is part of company’s filing submitted to the BSE.

Astec Lifesciences Share Price

791.90 3.65 (0.46%)
18-Jun-2026 12:15 View Price Chart
Peers
Company Name CMP
UPL 610.15
PI Industries 2837.05
Bayer CropScience 4251.05
Sharda Cropchem 908.70
Sumitomo Chemical 453.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: